• 1
    Pépin M, Bouloy M, Bird BH, Kemp A, Paweska JT. Rift Valley fever (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 2010; 41: 61.
  • 2
    Billecocq A, Spiegel M, Vialat P, et al. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004; 78: 97989806.
  • 3
    Ratovonjato J, Olive M, Tantely L et al. Detection, isolation, and genetic characterization of Rift Valley fever virus from Anopheles (Anopheles) coustani, Anopheles (Anopheles) squamosus, and Culex (Culex) antennatus of the Haute Matsiatra Region, Madagascar. Vector Borne Zoonotic Dis 2010; 11: 753759.
  • 4
    Sang RC, Ahmed O, Faye O et al. Entomologic investigations of a chikungunya virus epidemic in the Union of the Comoros. Am J Trop Med Hyg 2008; 78: 7782.
  • 5
    Andrewes C, Horstman D. The susceptibility of viruses to ethyl ether. J Gen Microbiol 1949; 3: 290297.
  • 6
    Craig D, Thomas W, DeSanctis A. Stability of Rift Valley fever virus at 4 °C. Appl Microbiol 1967; 15: 446447.
  • 7
    Francis T, McGill T. Rift Valley fever. A report of 3 cases of laboratory infection and the experimental transmission of the disease to ferrets. J Exp Med 1935; 62: 433438.
  • 8
    Easterday B. Rift valley fever. Adv Vet Sci 1965; 10: 65127.
  • 9
    Easterday BC, Murphy LC, Benett DG. Experimental Rift Valley fever in lambs and sheep. Am J Vet Res 1962; 23: 12311240.
  • 10
    Gerdes G. Rift Valley fever. Rev Sci Tech Off Int Epiz 2004; 23: 613623.
  • 11
    LaBeaud A, Muiruri S, Sutherland LJ et al. Postepidemic analysis of Rift Valley fever virus transmission in northeastern Kenya: a village cohort study. PLoS Negl Trop Dis 2011; 5: e1265.
  • 12
    Al-Hazmi M, Ayoola EA, Abdurahman M et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 2003; 36: 245252.
  • 13
    Breiman R, Minjauw B, Sharif S, Ithondeka P, Njenga MK. Rift Valley fever: scientific pathways toward public health prevention and response. Am J Trop Med Hyg 2010; 83(suppl 2): 14.
  • 14
    Dungu B, Louw I, Lubisi A, Hunter P, von Teichman B, Bouloy M. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep. Vaccine 2010; 28: 45814587.
  • 15
    Muller R, Saluzzo JF, Lopez N et al. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 1995; 53: 405411.
  • 16
    Kortekaas J, Zingeser J, De Leeuw P, Rocque DL, Unger H, Moormann R. Rift Valley fever vaccine development, progress and constraints. Emerg Infect Dis 2011; 17.
  • 17
    Mandell R, Flick R. Rift Valley fever virus: a real bioterror threat. J Bioterror Biodef 2011; 2: 108.
  • 18
    Linthicum KJ, Davies FG, Kairo A, Bailey CL. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg 1985; 95: 197209.
  • 19
    Linthicum K, Anyamba A, Tucker C, Kelley P, Myers M, Peters C. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 1999; 285: 397400.
  • 20
    Soti V, Tran A, Degenne P et al. Combining hydrology and mosquito population models to identify the drivers of Rift Valley fever emergence in semi-arid regions of West Africa. PLoS Negl Trop Dis 2012; 6: e1795.
  • 21
    Chevalier V, Lancelot R, Thiongane Y, Sall B, Diaite A, Mondet B. Rift Valley fever in small ruminants, Senegal, 2003. Emerg Infect Dis 2005; 11: 16931700.
  • 22
    Meegan J. The Rift Valley fever epizootic in Egypt 1977–78. 1. Description of the epizootic and virological studies. Trans Roy Soc Trop Med Hyg 1979; 73: 618623.
  • 23
    El-Akkad AM. Rift Valley fever outbreak in Egypt. October–December 1977. J Egypt Public Health Assoc 1978; 53: 123128.
  • 24
    Digoutte JP, Peters CJ. General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol 1989; 140: 2730.
  • 25
    Chevalier V, Rakotondrafara T, Jourdan M et al. An unexpected recurrent transmission of Rift Valley fever virus in cattle in a temperate and mountainous area of Madagascar. PLoS Neg Trop Dis 2011; 5: 19.
  • 26
    Nicolas G, Durand B, Duboz R, Rakotondravao R, Chevalier V. Description and analyses of trading network of cattle on Madagascar highlands and potential role in the diffusion of Rift Valley fever virus. Acta Trop 2012; 126: 1927. Available at:
  • 27
    Olive M, Goodman S, Reynes J. The role of wild mammals in the maintenance of Rift Valley fever virus. J Wildl Dis 2012; 48: 241266.
  • 28
    Ahmad K. More deaths from Rift Valley fever in Saudi Arabia and Yemen. Lancet 2000; 356: 1422.
  • 29
    Abd El-Rahim IHA, El-Hakim UA, Hussein M. An epizootic of Rift Valley fever in Egypt in 1997. Rev Sci Tech Off Int Epi 1999; 18: 741748.
  • 30
    Shoemaker T, Boulianne C, Vincent MJ et al. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000–2001. Emerg Infect Dis 2002; 8: 14151420.
  • 31
    Carroll S, Reynes J, Khristova M, Andriamandimby S. Genetic evidence for Rift valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance. J Virol 2011; 95: 61626167.
  • 32
    Russell R. Survival of insects in the wheel bays of a Boeing 747B aircraft on flights between tropical and temperate airports. Bull World Health Organ 1987; 65: 659662.
  • 33
    El Mamy A, Baba M, Barry Y et al. Unexpected Rift Valley fever outbreak, northern Mauritania. Emerg Infect Dis 2011; 17: 18941896.
  • 34
    World Health Organization. Rift Valley fever in Mauritania, D.O.N. WHO Global Alert and Response (GAR), Editor 2012, WHO. Available at:
  • 35
    El-Harrak M, Martin-Folgar R, Llorente F et al. Rift Valley and West Nile virus antibodies in camels, North Africa. Emerg Infect Dis 2011; 17: 23722374.
  • 36
    European Food Safety Authority. The risk of Rift Valley fever incursion and its persistence within the Community, in EFSA journal 2005. Parma: EFSA, 2005; 1128.
  • 37
    Chevalier V, Pépin M, Plée L, Lancelot R. Rift Valley fever—a threat for Europe? Euro Surveill 2010; 15: 111.
  • 38
    Moutailler S, Krida G, Schaffner F, Vazeille M, Failloux AB. Potential vectors of Rift Valley fever virus in the Mediterranean region. Vect Born Zoo Dis 2008; 8: 749753.
  • 39
    Moutailler S, Bouloy M. Short report: effcient oral infection of Culex pipien quinquefasciatus by RVF virus using a cotton stick support. Am J Trop Med Hyg 2007; 76: 827829.
  • 40
    Turell MJ, Bailey CL, Beaman JR. Vector competence of a Houston, Texas strain of Aedes albopictus for Rift Valley fever virus. J Am Mosq Control Assoc 1988; 4: 9496.
  • 41
    European Centre for Disease Prevention and Control. Areas of possible establishment of Aedes albopictus (the tiger mosquito) in Europe for 2010 and 2030. In: Impacts of Europe's changing climate—2008 indicator-based assessment. Stockolm: ECDC, 2008.
  • 42
    Roiz D, Neteler M, Castellani C, Arnoldi D, Rizzoli A. Climatic factors driving invasion of the tiger mosquito (Aedes albopictus) into new areas of Trentino, northern Italy. PLoS ONE 2011; 6: 18.
  • 43
    Jansen van Vuren P, Potgieter A, Paweska J, van Dijk A. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J Virol Methods 2007; 140: 106114.
  • 44
    Le Roux C, Kubo T, Grobbelaar A et al. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens. J Clin Microbiol 2009; 47: 647651.
  • 45
    Swanepoel R, Struthers JK, Erasmus MJ et al. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J Hyg (Lond) 1986; 97: 317329.
  • 46
    Tesh RB, Peters CJ, Meegan JM. Studies on the antigenic relationship among phleboviruses. Am J Trop Med Hyg 1982; 31: 149155.
  • 47
    Chu A, Savage R, Willison D et al. . The use of syndromic surveillance for decision-making during the H1N1 pandemic: a qualitative study. BMC Public Health 2012; 12: 929.
  • 48
    Leblond A, Hendrikx P, Sabatier P. West Nile virus outbreak detection using syndromic monitoring in horses. Vector Borne Zoonotic Dis 2007; 7: 404410.
  • 49
    InVS. Bulletin de veille sanitaire N°02/Novembre 2009. InVS: La Réunion, France, 2009.
  • 50
    Anyamba A, Linthicum K, Small J et al. Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006–2008 and possible vector control strategies. Am J Trop Med Hyg 2010; 83(suppl 2): 4351.
  • 51
    Stärk KD, Regula G, Hernandez J et al. Concepts for risk-based surveillance in the field of veterinary medicine and veterinary public health: review of current approaches. BMC Health Serv Res 2006; 28: 620.
  • 52
    Boroushaki S, Malczewski J. Using the fuzzy majority approach for GIS-based multicriteria group decision-making. Comput Geosci 2010; 36: 302312.